Diabetic foot infections: a team-oriented review of medical and surgical management by Capobianco, Claire M & Stapleton, John J
Diabetic foot infections: a team-oriented
review of medical and surgical
management
Claire M Capobianco, DPM
1* and John J Stapleton, DPM, FACFAS
2,3
1Division of Podiatric Medicine and Surgery, Department of Orthopaedic Surgery, University of Texas Health
Science Center at San Antonio, San Antonio, TX, USA;
2Foot and Ankle Surgery, VSAS Orthopaedics,
Allentown, PA, USA;
3Department of Surgery, Penn State College of Medicine, Hershey, PA, USA
As the domestic and international incidence of diabetes and metabolic syndrome continues to rise, health care
providers need to continue improving management of the long-term complications of the disease. Emergency
department visits and hospital admissions for diabetic foot infections are increasingly commonplace, and a
like-minded multidisciplinary team approach is needed to optimize patient care. Early recognition of severe
infections, medical stabilization, appropriate antibiotic selection, early surgical intervention, and strategic
plans for delayed reconstruction are crucial components of managing diabetic foot infections. The authors
review initial medical and surgical management and staged surgical reconstruction of diabetic foot infections
in the inpatient setting.
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F
oot ulceration and infection occur frequently and
can deteriorate rapidly in the insensate diabetic
patient. Frequently, infections in this patient
population are masked by neuropathy and complicated
by concomitant metabolic derangements, peripheral
arterial disease, and immunocompromise (1, 2). Hence,
management of these patients requires a like-minded,
multidisciplinary team strategy for medical stabilization
and infection control via adequate surgical debridement,
antibiotic selection, and delayed reconstruction to achieve
functional limb salvage (35).
Multiple classification systems exist for diabetic ulcera-
tion and diabetic foot syndrome, which inherently over-
lap. The most widely recognized classification is the
Wagner system, which grades ulcers from 0 to 5 based
largely on ulcer depth and severity (6). Although easy to
remember, this system fails to address peripheral arterial
disease, peripheral neuropathy, ulcer dimensions, or the
extent of infection.
Other diabetic ulcer descriptors that are commonly
used in the literature and have been validated include the
University of Texas (UT) Classification and the PEDIS
classification. The UTsystem is easy to use and addresses
not only the wound depth, but also the presence or
absence of infection and the presence or absence of
ischemia (7). The PEDIS system is even more detailed
and was developed by the International Working Group
on the Diabetic Foot primarily for research purposes.
PEDIS is a detailed classification system that describes
each of the following ulceration characteristics on a scale
of 1 to 4, depending on severity: Perfusion, Extent (or
size), Depth, Infection, and Sensation (8).
Initial evaluation: determination of infection
severity
Although the classification of ulceration itself is impor-
tant, the simple stratification of the diabetic patient’s
overall clinical status takes obvious precedence in the
emergency or inpatient setting. The Infectious Disease
Society of America delineates diabetic foot infections into
four straightforward categories in their published guide-
lines in 2004 (9). Infections are described based on the
composite of the clinical appearance of the foot and the
systemic condition of the patient: uninfected (lacking
purulence or inflammation); mild (infection limited to
skin/subcutaneous tissue, peri-wound erythema of less
than 2 cm, and less than two signs of inflammation);
moderate (involvement of muscle, joint, bone, or presence
of lymphangiitis, peri-wound cellulitis beyond 2 cm, or
gangrene); or severe (infection in a patient with systemic
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foot infection, which includes wet gangrene, necrotizing
fasciitis, or an abscess resulting in systemic toxicity can
quickly become limb- or life-threatening and requires
early and appropriate antibiotic selection and surgical
debridement. In addition, the authors categorize an
infected ulcer with an associated unstable Charcot
deformity as a severe infection given the high morbidity
associated with this clinical presentation.
Diabetic patients may or may not mount a fever, even
in the presence of severe infection, but may manifest
other constitutional symptoms. Hypotension, tachycar-
dia, and severe unexplained hyperglycemia are often
noted, but greater than 50% of limb threatening infec-
tions do not manifest systemic signs or symptoms (10).
Initial blood work includes a basic metabolic panel,
complete blood count with differential, urinalysis, and
blood cultures. A glycosylated hemoglobin, erythrocyte
sedimentation rate, and C-reactive protein are often
added for a more complete assessment of the glycemic
control and degree of systemic response at the time of
presentation. Evaluation of the overall nutritional status
of the patient via serum albumin and pre-albumin levels
is also important to optimize wound healing conditions
in the setting of increased metabolic demands.
Additionally, the evaluation of initial radiographs is
crucial in determining the severity of the infection.
Osteomyelitis, gas in the soft tissues, or the presence of
a foreign body implies violation and involvement of deep
soft tissue planes. In the neuropathic population specifi-
cally, radiographs should be assessed for osseous defor-
mities, fractures, and/or dislocations that could indicate
acute Charcot neuroarthropathy.
It goes without saying that the physical evaluation of
the foot is paramount for the determination of the severity
of infection. Careful palpation for fluctuance or tunneling
wounds is important because these imply deep space
infections that have the potential to spread more easily
along tissue planes (11, 12). Sensation must also be
examined closely; pain on palpation of any area of an
insensate foot is concerning for more severe infection (12).
The violation of dermal and subcutaneous layers is not
uncommon in diabetic foot ulceration and an evaluation
of the depth of ulceration is important. If a clinically
infected ulceration probes to bone on examination,
studies have demonstrated 8995% positive predictive
value (PPV) of this test for contiguous osteomyelitis (13,
14). Other studies involving both infected and non-
infected ulcerations have shown a lower PPV but a
greater than 91% negative predictive value (1416). Taken
together, these data imply that, in a clinically infected
ulcer, a positive probe-to-bone test has a high correlation
with underlying osteomyelitis. Importantly though, a
negative probe-to-bone test in the setting of a clinically
infected ulcer does not and cannot rule out underlying
osteomyelitis (17) (see Fig. 1).
Furthermore, the initial evaluation of the presence or
absence of limb ischemia is crucial to categorize the
superimposed risk of limb loss. The degree of impaired
distal perfusion significantly increases the overall severity
of the infection (2). The surgeon should palpate for the
presence or absence of pedal and popliteal pulses, and
signs of ischemia, necrosis, and gangrene should be
noted. A cursory handheld Doppler exam, performed
by the surgeon in the emergency department, can give a
gross idea of the degree of impairment of distal perfusion
without any delay in the progression of treatment.
Further vascular workup and intervention are deter-
mined once local control of infection via surgical
debridement is performed.
Fig. 1. A clinical presentation of a diabetic Charcot foot with
plantar ulceration that will require staged osseous and soft
tissue reconstruction.
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medical stabilization
In the emergency department, initial parenteral antibiotic
selection ought to provide a broad-spectrum coverage of
Gram positive, Gram negative, and anaerobic organisms
(1822). Patients with diabetic foot infections ought to
receive early consultation with a podiatric surgeon and
early cardiac risk stratification by the medicine team so as
to determine the severity of the infection and the timing
for surgical intervention, when appropriate.
For severe diabetic foot infections, one, or a combina-
tion, of the following broad-spectrum antibiotics are
recommended: piperacillin-tazobactam, vancomycin,
levofloxacin or ciprofloxacin with clindamycin, or imipe-
nam-cilistatin (18). Characteristic odors and personal
history of resistant bacterial infections may also con-
tribute to the selection of initial antibiotic agents.
Methicillin-resistant Staphylococcus aureus (MRSA) is
frequently a pathogen in community as well as hospital-
acquired infections and has been associated with poor
clinical outcomes (23, 24). For this reason, agents with
MRSA coverage specific to hospital antibiograms are
often started empirically.
Many emergency departments and some specialists
immediately obtain superficial soft tissue cultures from
diabetic foot wounds. Some literature reports similar
findings between superficial swab cultures obtained from
chronic wounds and those swabs obtained via deep tissue
culture techniques (2527). Other investigators have
postulated that the pathogenic concurrence between
swab and biopsy specimens is not perfect but is usually
sufficient (28, 29). Conversely, many believe that super-
ficial swab cultures of infected ulcers only complicate
the evaluation of the patient, as these cultures may
not convey anaerobic and fastidious bacterial presence
(2535).
The swab culture debate is important because severe
diabetic foot infections are frequently found to be
polymicrobial, with mixed aerobic and anaerobic species
of bacteria and occasionally fungus (25, 27, 28). Mild or
moderate infections, on the other hand, often have one
primary pathogen, which is most frequently S. aureus (26,
36, 37). Additionally, the increasing prevalence of MRSA
in diabetic foot infections has been associated with
wound healing complications and a higher risk of lower
extremity amputation (38, 39). Without a doubt, defini-
tive antibiotic therapy is based on culture and sensitivity
results from intra-operative cultures and the input of the
infectious disease members of the team to determine
which organisms are true pathogens.
In the diabetic patient, the degree of end-organ
dysfunction frequently affects multiple facets of medical
and surgical management during the hospitalization.
Antibiotic dosing, cardiac function parameters, meta-
bolic instability, ketoacidosis, distal lower extremity
perfusion, immunosuppression, nutritional status, and
healing potential of the lower extremity are all frequently
compromised.
The goal of medical management for the patient with a
severe diabetic foot infection is to regulate and normalize
the metabolic and hemodynamic derangements present
and to prevent further decompensation (40, 41). Com-
monly, severe hyperglycemia, ketoacidosis, hyperosmol-
ality, and azotemia are present at the initial presentation
(42), especially in severe diabetic foot infections. Addi-
tionally, accompanying osmotic diuresis and/or fluid
depravation from vomiting may cause hyponatremia,
hypokalemia, and acute-on-chronic renal insufficiency.
Moreover, borderline hypokalemia is often treated so as
to prevent the anticipated decrease in serum potassium
after correction of hyperglycemia.
The medicine team augments cardiac and renal protec-
tion with careful control of blood pressure, initiation of
angiotensin-converting enzyme inhibitor therapy, and
diligent parental fluid management.Previous records,
especially cardiac stress tests and cardiac echography,
are comprehensively reviewed and the need for repeat
cardiac studies is urgently evaluated if general anesthesia
is needed for initial surgical decompression and drainage
of the infection. Because infection and gangrene result in
increased cardiac demands, a target hematocrit is often
established based on the patient’s cardiac risk profile.
Most diabetic patients with severe infections have anemia
of the chronic disease at baseline and will be expected to
lose additional heme with repeat surgical debridement,
but transfusion needs are assessed on an individualized
basis.
As with all diabetic admissions, oral hyperglycemic
agents are held and glycemic control is obtained through
an insulin correction scale according to the insulin
sensitivity factor (ISF). The goal of such a scale is to
maintain an inpatient’s premeal blood sugar range
between 80 and 140 mg/dL and their maximum random
blood sugar level below 180 mg/dL. An insulin correction
scale considering an ISF is safer, more efficient, and more
patient-specific than the standard sliding scale correction
and because it is based on the patient’s physiologic
demand. Because infection typically perpetuates hyper-
glycemia, the adaptability and ease of dosing adjustment
afforded by insulin facilitates tight glycemic control in the
inpatient setting.
Additionally, the potential for iodinated contrast
administration during the hospitalization, especially in
the setting of critical limb ischemia, must be expected.
The limb salvage team needs to appreciate and foster
the facilitation of metabolic control of the patient
through surgical control of the infection, as infection
is the primary etiology of the severe metabolic distur-
bance (10).
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After the patient is medically stabilized, initial surgical
debridement is performed with the goal of resecting all
non-viable tissue and decompressing gross abscesses. In
severe diabetic foot infections, all members of the team
must understand that early decompression and drainage
is crucial to successful control of the infection and must
occur as soon as the patient’s metabolic disturbances have
been addressed. Even in mild or moderate diabetic foot
infections, the authors advise caution in ordering
advanced imaging studies prior to initial surgical inter-
vention, as these may unnecessarily delay surgery.
In mild or moderate diabetic foot infections, local
anesthesia may be used, but often, general anesthesia is
warranted in severe infections, as the depth of infection
and fascial spread may be extensive. Resection of all
sloughed and congested skin and the exploration of all
sinus tracts are essential and blunt dissection is used to
determine the extent of involvement of the fascial planes.
Tissue planes that are easily violated with minimal
pressure during manual exploration indicate the possibi-
lity of necrotizing fasciitis, which has a significantly worse
prognosis (43).
After thorough exploration of the affected pedal
compartments, the surgeon is able to determine the
necessary amputation level or the degree of wide excision
needed. All non-viable and infected soft tissue and
bone must be excised during the initial debridement to
enable wound healing. Additionally, the degree of intra-
operative bleeding after resection of non-viable tissue
must be assessed (4447). Exposed tendons should be
excised if proximal migration of the infection is suspected
and all marginal-appearing tissue should be resected to
foster better wound bed granulation. Deep soft tissue and
bone intra-operative cultures are sent to microbiology
and bone may be sent for histopathological examination
if osteomyelitis is suspected (see Fig. 2).
Definitive surgical management
Many patients with life- or limb-threatening diabetic foot
infections have concomitant peripheral arterial disease
that complicates their wound healing potential. For this
reason, if pedal pulses are non-palpable or mono/biphasic
via the handheld Doppler signals, or if minimal bleeding
is visualized during the initial surgical debridement, non-
invasive vascular studies should be ordered without delay
following initial debridement. Ankle and toe brachial
indices, pulse volume recordings, and transcutaneous
oxygen pressures provide valuable information that
ultimately determines the appropriateness of vascular
surgery consultation and invasive vascular studies.
The Ankle Brachial Index (ABI), or the ratio of the
systolic ankle blood pressure to the standard systolic
brachial blood pressure, is a useful screening test because
any result less than 1.0 (in a diabetic or non-diabetic
patient) strongly suggests significant peripheral arterial
compromise. Unfortunately, the ABI may underestimate
the severity of arterial insufficiency in the diabetic
population, as it is significantly affected by incompres-
sible calcified vessels. Calcification of the tunica media,
called Moneckberg’s sclerosis, is commonly seen in
diabetic patients and results in falsely elevated ABI
values. Hence, despite clinical signs of impaired perfu-
sion, the ABI may ‘appear’ to be within normal limits
(48). Furthermore, segmental decreases of 2030 mmHg
between proximal and distal arterial segments may
represent occlusive peripheral vascular disease in the
affected arterial segment and may warrant further
evaluation by the vascular surgeons.
Because of the inherent weakness of the ABI for
vascular screening in diabetic patients, qualitative wave
forms and toe-brachial pressure indices are typically
included in the non-invasive vascular exam (49). Addi-
tionally, some institutions also employ transcutaneous
oxygen pressure measurements (TCPO2), which can be
useful in predicting the wound healing capacity at
different levels in the foot (5052). The TCPO2 values
greater than 30 mmHg suggest significantly improved
chances of healing compared with those less than
30 mmHg (5052). As with all measurements, the
TCPO2 values should not be evaluated in isolation as an
indicator of healing. In fact, the presence of edema and
cellulitis affects TCPO2 readings significantly, and caution
must be exercised with interpretation in these situations.
In the severe diabetic foot infection, suboptimal
non-invasive study results potentiate timely vascular
surgery consultation and, often, angiography (53).
Revascularization, if needed, is ideally performed within
12 days after the initial surgical debridement (54, 55).
Percutaneous transluminal angioplasty is now the typical
initial intervention in the salvage of the ischemic diabetic
limb, but may be followed, if necessary, by open distal
arterial bypass (2, 55).
Fig. 2. A clinical presentation of a staged diabetic limb salvage
procedure including aggressive initial surgical debridement
followed by a partial calcanectomy.
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perfusion is essential before definitive soft tissue recon-
struction can occur. If osteomyelitis is confirmed from
initial deep cultures or histopathology, further aggressive
resection of all affected bone is warranted. Depending on
the bone affected, location, and overlying soft tissue
envelope, proximal amputation may suffice. When resec-
tion of osteomyelitis is more extensive, involving multiple
bones, associated with Charcot neuroarthropathy, or
results in significant instability in the foot, adjunctive
implantation of organism-specific antibiotic beads is
often performed. Provisional soft tissue closure over the
beads is often obtainedwith local soft tissue coverage, but
may also employ negative pressure wound therapy
dressings or external fixation to reduce large soft tissue
defects (56).
Parenteral antibiotics are continued in the outpatient
setting per infectious disease recommendations. Strict
non-weightbearing and biweekly office follow-up visits
occur until an explantation of the beads is planned.
Antibiotic beads may be left in place for time periods
ranging from 2 weeks to permanently, but explantation
typically occurs approximately 6 to 9 weeks after inser-
tion of the beads (57, 58).
After eradication of all grossly infected soft tissue and
osteomyelitis, staged reconstruction is planned. Signifi-
cant osseous involvement may potentiate underlying
instability and cause further deformity and morbidity in
this high-risk patient population. For this reason, adjunc-
tive osseous procedures may be warranted to restore
stability and address deformity in the insensate foot in
order to minimize ulcer recurrence. The selection of
osseous procedures is patient and pathology dependent
and may range from simple exostectomy to extended
medial column arthrodeses with internal and/or external
fixation methods. In diabetic foot infections and ulcera-
tions, soft tissue management is as important as osseous
reconstruction. The reconstructive pyramid, an algorithm
that details the soft tissue reconstructive options from
simplest and most utilized to most complex and least
employed, is frequently referred to during preoperative
planning.
Often, significant tissue deficits preclude primary
closure following aggressive surgical debridement of
severe diabetic foot infections. When feasible, the least
invasive methods of coverage are employed, such as
delayed primary closure or partial closure with wound
healing adjuncts such as negative pressure wound therapy.
Many wounds are not amenable to delayed primary
closure and require plastic surgical techniques including,
from least to most complicated, split thickness skin
grafting (59), local rotational or advancement flaps
(6063), muscle flaps (6467), or pedicle flaps(6870)
(see Fig. 3).
Goals for surgery are discussed in-depth on a patient-
by-patient basis, and family presence in these discussions
is strongly encouraged. In general, in previously or
potentially ambulatory patients, the ultimate goal of
both soft tissue and osseous reconstruction is restoration
of a functional, plantigrade, shoeable or braceable foot
that is free of ulceration. In previously non-ambulatory
patients, the goal of surgery is eradication of infection and
provision of a stable, ulcer-free foot to aid in transfers.
Discussion
Diabetic limb salvage requires the collaboration of a
finely tuned, multidisciplinary team and the implementa-
tion of a logical stepwise approach for medical and
surgical approaches to the severe infection. The goal of
limb salvage is to maintain  or provide  a limb that is
functional, plantigrade, durable, stable, and shoeable or
braceable. Patient stabilization, medical optimization,
aggressive surgical debridement, parenteral antibiotics,
vascular assessment/intervention, and delayed soft tissue
and osseous reconstruction are all critical components of
a successful treatment algorithm for the severe diabetic
foot infection.
Fig. 3. A clinical presentation of a severe diabetic foot infection
that necessitates urgent/emergent surgical debridement and/or
amputation.
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